Revolution Medicines, Inc. RVMD
Set alert
191.31 USD +1.04 +0.55%
At close · Oct 30
191.25 -0.06 -0.03%
After hours · Oct 30, 7:33 PM ET
187.28 Day range 192.60
58.57 52-week range 221.15
- YTD
- +140.19%
- 1 year
- +224.97%
- Open
- 188.38
- Prev close
- 190.27
- Mkt cap
- 41.00B
- Vol
- 1.10M
- Avg vol
- 1.94M
- EPS
- -8.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 187.28
- High
- 192.60
- Forward P/E
- -33.19
- Beta
- 1.40
- Short ratio
- 5.55
- Inst. own
- 102.37%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 199.63
- 200-d avg
- 155.69
- 1y target
- 258.84
1Y chart
Events in this range
- Nov 5, 2025Earnings: -1.61; estimate -1.42; surprise -13.38%
- Feb 25, 2026Earnings: -1.86; estimate -1.58; surprise -17.72%
- May 6, 2026Earnings: -2.29; estimate -1.84; surprise -24.46%
- Aug 5, 2026Earnings: -3.06; estimate -2.04; surprise -50%
- Oct 8, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 14, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 15, 2026Rating: Needham · Buy → Buy
- Oct 16, 2026Rating: William Blair · — → Outperform
- Oct 19, 2026Rating: Truist Securities · Buy → Buy
- Oct 21, 2026Rating: TD Cowen · Buy → Buy
Signals (31)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 2026 | 3 days ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| RSI: Overbought | Aug 27, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 18, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| RSI: Overbought | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Apr 2, 2026 | 7 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 3, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| RSI: Overbought | Jan 7, 2026 | 9 months ago |
| RSI: Overbought | Dec 24, 2025 | 10 months ago |
| RSI: Overbought | Dec 22, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 9, 2025 | 10 months ago |
Compare RVMD
Chart and line up RVMD against other symbols or a saved comparison set.
- RVMD Revolution Medicines, Inc.
191.31
+1.04 +0.55%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | RVMD | SPY | QQQ |
|---|---|---|---|
| Last price | 191.31 | 755.72 | 690.49 |
| Change | +1.04 | -13.64 | -24.85 |
| Change % | +0.546592% | -1.77% | -3.47% |
| Open | 188.38 | 761.38 | 697.13 |
| Day high | 192.60 | 761.46 | 698.63 |
| Day low | 187.28 | 750.36 | 683.45 |
| Previous close | 190.27 | 769.36 | 715.34 |
| Volume | 1.10M | 77.70M | 85.24M |
| Average volume | 1.94M | 41.22M | 34.57M |
| Market cap | 41.00B | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -8.87 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 221.15 | 779.09 | 759.66 |
| 52-week low | 58.57 | 631.97 | 558.28 |
| 1-week return | +2.31% | -0.559233% | -1.97% |
| 1-month return | -6.80% | -0.906075% | -6.66% |
| 3-month return | -0.44752% | +1.89% | +1.02% |
| 6-month return | +32.74% | +5.16% | +3.41% |
| Year-to-date return | +140.19% | +10.82% | +12.40% |
| 1-year return | +224.97% | +11.16% | +10.29% |
| 2-year return | +257.59% | +32.90% | +42.71% |
| 50-day moving average | 199.63 | 767.63 | 725.41 |
| 200-day moving average | 155.69 | 728.53 | 679.17 |
| Target price | 258.84 | — | — |
| Beta | 1.40 | 0.00 | 0.00 |
| Short ratio | 5.55 | — | — |
| Institutional ownership | 102.37% | — | — |